George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 9.00
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 0.50 (5.556%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

6 Dec 2021 14:05

RNS Number : 7152U
SkinBioTherapeutics PLC
06 December 2021
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMGZMGZDVKGMZM

Date   Source Headline
29th May 20187:00 amRNSSkinBioTherapeutics involved in new research grant
14th May 20187:00 amRNSSkinBioTherapeutics files new patent application
1st May 20187:00 amRNSSkinBioTherapeutics plans for human study
24th Apr 20188:56 amRNSHolding(s) in Company
17th Apr 20187:00 amRNSPositive cream formulation results for SkinBiotix
3rd Apr 20187:00 amRNSSBTX signs MTA with global consumer goods company
21st Feb 20187:00 amRNSHalf year results
16th Feb 201810:02 amRNSNotice of Interim Results
5th Jan 20187:00 amRNSAppointment of Joint Broker
1st Dec 20177:05 amRNSNotification of first patent grant
9th Nov 20177:00 amRNSSkinBiotix platform passes external toxicity tests
8th Nov 201711:32 amRNSSkinBioTherapeutics to present at investor evening
30th Oct 201711:23 amRNSResult of AGM
5th Oct 20177:00 amRNSFinal Results
3rd Oct 20177:00 amRNSCytotoxicity results and scientific update
27th Sep 20179:00 amRNSNotice of Results
12th Sep 20178:54 amRNSHolding(s) in Company
19th Jun 20179:00 amRNSSkinBioTherapeutics to Present at Investor Evening
9th Jun 201710:38 amRNSHolding(s) in Company
23rd May 20173:21 pmRNSHolding(s) in Company
23rd May 20177:00 amRNSExtension of Research Contract
5th Apr 20177:00 amRNSFirst day of dealings - to trade under SBTX ticker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.